StonvexLoading…
StonvexStonvexStonvexCore line items from BTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | £25.61B | £25.87B | £27.28B | £27.66B |
Operating Income | £10.00B | £2.74B | £-15.75B | £10.52B |
Net Income | £7.76B | £3.18B | £-14.19B | £6.85B |
EPS (Diluted) | £3.49 | £1.36 | £-6.47 | £2.92 |
Total Assets | £109.29B | £118.90B | £118.72B | £153.55B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | £3.83B | £5.30B | £4.66B | £3.45B |
Free Cash Flow OCF − CapEx | £5.79B | £9.64B | £10.25B | £9.87B |
Shares Outstanding | Not available | Not available | Not available | Not available |